All posts from Zacks
Zacks in Our Research. Your Success.,

Will Ligand Pharmaceuticals (LGND) Continue to Surge Higher?

Ligand Pharmaceuticals Inc. LGND has been on the move lately as the stock has risen by 10.8% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on LGND is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
LIGAND PHARMA-B (LGND): Free Stock Analysis Report
To read this article on click here.